- Home
- VNDA
as 10-23-2025 3:54pm EST
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Upcoming Earnings Alert:
Get ready for potential market movements as Vanda Pharmaceuticals Inc. VNDA prepares to release earnings report on 29 Oct 2025.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | 249.4M | IPO Year: | 2006 |
| Target Price: | $16.50 | AVG Volume (30 days): | 562.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.81 - $5.59 | Next Earning Date: | 10-29-2025 |
| Revenue: | $203,467,000 | Revenue Growth: | 11.78% |
| Revenue Growth (this year): | 15.45% | Revenue Growth (next year): | 37.82% |
Latest Vanda Pharmaceuticals Inc. News
VNDA Breaking Stock News: Dive into VNDA Ticker-Specific Updates for Smart Investing
Simply Wall St.
20 hours ago
High Growth Tech Stocks in the US to Watch for October 2025
PR Newswire
a day ago
Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025
Simply Wall St.
3 days ago
Exploring High Growth Tech Stocks In The US Market
Simply Wall St.
4 days ago
Exploring High Growth Tech Stocks in the US This October 2025
Simply Wall St.
8 days ago
US High Growth Tech Stocks To Watch For Potential Expansion
Simply Wall St.
8 days ago
Exploring 3 High Growth Tech Stocks in the US Market
Simply Wall St.
10 days ago
High Growth US Tech Stocks To Watch In October 2025
Simply Wall St.
15 days ago
High Growth Tech Stocks in US Market for October 2025
Compare VNDA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VNDA Vanda Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.